Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Short Interest Update

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the target of a large drop in short interest during the month of April. As of April 30th, there was short interest totalling 16,400 shares, a drop of 64.7% from the April 15th total of 46,500 shares. Based on an average daily volume of 381,400 shares, the short-interest ratio is presently 0.0 days.

Ono Pharmaceutical Stock Down 0.6 %

OTCMKTS:OPHLY traded down $0.03 during trading hours on Friday, hitting $4.86. 199,691 shares of the company were exchanged, compared to its average volume of 103,897. Ono Pharmaceutical has a one year low of $4.68 and a one year high of $6.74. The company has a fifty day simple moving average of $5.22 and a 200 day simple moving average of $5.60.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.